Cite

HARVARD Citation

    Subrahmanyam, P. et al. (2018). Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients. Journal for immunotherapy of cancer. 6 (1), p. . [Online]. 
  
Back to record